Rockefeller Institute.
Name Entries
corporateBody
Rockefeller Institute.
Computed Name Heading
Name Components
Name :
Rockefeller Institute.
Genders
Exist Dates
Biographical History
In 1892, the physician and medical administrator Simon Flexner began research on cerebrospinal meningitis, a meningococcal disease with an untreated mortality rate between 70 and 90%. Experimenting on monkeys, Flexner developed a promising serum treatment for the disease by 1903, which he used extensively during the epidemic outbreaks of meningitis in New York City in 1904-1905 and 1907. For several years, Flexner kept his serum under his close supervision, with the result that the Rockefeller Institute became the primary source for knowledge about meningitis and its treatment.
eng
Latn
External Related CPF
https://viaf.org/viaf/134912552
https://www.worldcat.org/identities/lccn-n84004720
https://id.loc.gov/authorities/n84004720
Other Entity IDs (Same As)
Sources
Loading ...
Resource Relations
Loading ...
Internal CPF Relations
Loading ...
Languages Used
Subjects
Epidemics
Epidemiology
Meningitis
Serum
Nationalities
Activities
Occupations
Legal Statuses
Places
Convention Declarations
<conventionDeclaration><citation>VIAF</citation></conventionDeclaration>